Hester Biosciences surged 5.38% to Rs 1,710 at 12:47 IST on BSE after net profit rose 11.68% to Rs 6.50 crore on 10.31% growth in total revenue to Rs 32.29 crore in Q3 December 2017 over Q3 December 2016.
The result was announced during market hours today, 23 January 2018.Meanwhile, the S&P BSE Sensex was up 334.38 points or 0.93% at 36,132.39. The S&P BSE Small-Cap index advanced 0.48%, underperforming the Sensex.
On the BSE, 15,000 shares were traded on the counter so far as against average daily volumes of 4,230 shares in the past one quarter. The stock had hit a high of Rs 1,818.95 and a low of Rs 1,648.80 so far during the day. The stock had hit a record high of Rs 1,949.80 on 26 December 2017 and a 52-week low of Rs 716 on 22 March 2017.
The small-cap company has equity capital of Rs 8.51 crore. Face value per share is Rs 10.
Hester Biosciences said that its wholly owned subsidiary Hester Biosciences Africa has completed the market survey. The prospects to set up an animal vaccine manufacturing unit in Tanzania seem to be emerging, it added.
Hester Biosciences is one of India's leading animal healthcare companies and second largest poultry vaccine manufacturer.
Powered by Capital Market - Live News